Basic research and applications coexist in a tangled two-way ecosystem.
A new study connects the dots between published science and patented innovations, mapping just how society benefits from basic scientific research.
Are research nonprofits holding up their end of the tax-exempt bargain?
Holding patents can be a lucrative and powerful position to be in. Here's a proposal for how nonprofit patent holders can do more for the common good – and live up to their end of the tax break bargain.
Fixing electronics devices doesn’t need to be difficult.
Many companies are working to prevent customers from fixing broken smartphones and tractors. By doing so, they're missing out on an opportunity to build customer loyalty and boost profits.
This is what a marijuana plant, growing legally in Colorado, looks like.
The federal government outlaws marijuana, but many states are legalizing it. Coupled with the growing number of cannabis-related patents, the potential for court battles is dizzying.
The high cost of cancer drugs in South Africa has come under the spotlight with an investigation by the Competition Commission in the country.
If the government wants to encourage universities to translate their research to a wider audience, they should explicitly pay for it.
In March 2018, all Australian universities will be submitting key performance indicators (KPIs) on their engagement and impact to the Australian Research Council. These measure how well universities engage…
The UK is the latest country where tobacco companies cannot market their brands on their packets.
Elon Musk struck a blow for open IP, so should other sustainable industries go the same way?
A New York Times article from 1910 describes founding of Mound Bayou, a town founded on the wealth of a steamboat patent.
American slaves couldn't hold property – including patents on their own inventions. But that didn't stop black Americans from innovating since the beginning of the country's history.
They’re still often more expensive overseas than in Australia.
The copyright wars are set to continue, with the government releasing a Productivity Commission report arguing for a relaxation of intellectual property laws.
Obama annually welcomed students to the White House with their Science Fair projects.
AP Photo/Susan Walsh
The outgoing president leaves behind some solid accomplishments in the world of science, tech and medicine. But the biggest departure from his predecessors might have been in his approach.
The ruling in the Apple-Samsung case is ambiguous, ensuring the case will drag on for years more, potentially even ending up back in the Supreme Court.
If the UK is so intent on a 'hard Brexit', why did it just ratify a court that gives the EU jurisdiction over patent disputes?
Cheerleaders and smartphones are in the Supreme Court’s hands.
The Supreme Court is considering two cases stemming from the merger of design and function that could reshape intellectual property law. Can we protect innovation without impeding fair competition?
Finding the way from lab bench to patent office can be hard.
Australia has never been short of inventors, scientists aren't always at home in the ruthless world of commerce. But if they can be given a helping hand, it could help the entire economy.
How much did Samsung’s phone sales depend on it looking like an iPhone?
Design patents cover how products look – but how much does appearance contribute to profits?
OlegD / shutterstock.com
Why drug maker Mylan's decision to introduce a half-price version of its EpiPen could be more than a publicity stunt.
Trophy and hands via shutterstock.com
Google saves $9 billion, programmers and users get to keep a popular language and its apps – and a key Oracle product stays alive.
Copyright is currently skewed in favour of producers, not consumers.
The Productivity Commission's report into copyright reform will be good for the public, good for innovation and good for Australia.
A patent has far-reaching implications for future research.
U.C. Berkeley and the Broad Institute are fighting to control the patents on the revolutionary gene-editing technology. But there's a lot more at stake than just who gets the credit and licensing fees.